Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan and Amoxicillin Dual Therapy for H. pylori
NCT05649709Phase 4Completed
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Feb 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vonoprazan in Helicobacter pylori infection, sponsored by First Affiliated Hospital of Nanchang University. Started Feb 2023; status: completed.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05649709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05649709.